200064-11-5

Basic information

• Product Name: 4-(5-BROMOPYRIDIN-2-YL)MORPHOLINE
• Synonyms: 5-bromo-2-(morpholine-1-yl)pyridine;N-(5-Bromopyridin-2-yl)morpholine;4-(5-Bromopyridin-2-yl)morpholine;5-bromo-2-(4-morpholinyl)pyridine;5-Bromo-2-(morpholin-4-yl)pyridine;5-BroMo-2-Morpholinopyridine
• CAS NO: 200064-11-5
• Molecular Formula: C₉H₁₁BrN₂O
• Molecular Weight: 243.1
• Product Categories: pharmacetical;Pyridine series;Halides;Pyridines;Organohalides;Pyridine;alkyl bromide
• Mol File: 200064-11-5.mol
• Article Data: 25

Chemical Properties

• Boiling Point: 354.545 °C at 760 mmHg
• Flash Point: 168.223 °C
• Appearance: /
• Density: 1.499 g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.578
• Storage Temp.: Inert atmosphere,Room Temperature
• PKA: 3.35±0.10(Predicted)
• CAS DataBase Reference: 4-(5-BROMOPYRIDIN-2-YL)MORPHOLINE(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(5-BROMOPYRIDIN-2-YL)MORPHOLINE(200064-11-5)
• EPA Substance Registry System: 4-(5-BROMOPYRIDIN-2-YL)MORPHOLINE(200064-11-5)

Safety Data

• Hazard Codes: T
• Statements: 25
• Safety Statements: 45
• HazardClass: IRRITANT
• Hazardous Substances Data: 200064-11-5(Hazardous Substances Data)

Usage

General Description

4-(5-Bromopyridin-2-yl)morpholine is a chemical compound with the molecular formula C10H12BrN2O. It is a highly versatile organic building block that is commonly used in the synthesis of pharmaceuticals, agrochemicals, and other fine chemicals. 4-(5-BROMOPYRIDIN-2-YL)MORPHOLINE is a heterocyclic compound containing a morpholine ring, which imparts unique chemical reactivity and properties. It is commonly employed as a reagent in organic synthesis, particularly in the formation of carbon-nitrogen bonds. Additionally, it is used in the development of various biologically active compounds and drug candidates due to its potential pharmacological properties. Ongoing research is being conducted to explore its potential applications in medicinal chemistry and drug discovery.

InChI:InChI=1/C9H11BrN2O/c10-8-1-2-9(11-7-8)12-3-5-13-6-4-12/h1-2,7H,3-6H2

Upstream product

• 110-91-8 morpholine 
• 624-28-2 2,5-dibromopyridine 
• 5414-19-7 1,1'-oxybis(2-bromo-ethane) 
• 13534-99-1 2-Amino-3-bromopyridine 
• 766-11-0 5-bromo-2-fluoropyridine 
• 53939-30-3 5-bromo-2-chloropyridine 

Downstream Products

• 485799-04-0 4-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl]morpholine 
• 1333415-91-0 4-(5-((trifluoromethyl)thio)pyridin-2-yl)morpholine 
• 265107-43-5 1-(6-morpholin-4-yl-pyridin-3-yl)-ethanone 
• 904326-93-8 [6-(morpholin-4-yl)pyridin-3-yl]boronic acid 

Relevant articles and documents

Azaindole derivative myelocyte proliferation inhibitor, preparation method thereof, and application of inhibitor in pharmacy

The invention provides an azaindole derivative myeloid proliferation inhibitor as shown in a formula I. In the formula, R1, R2 and R33 are as defined in the specification. The compound shown in the formula I can be used for remarkably inhibiting the proliferation of myeloid cells represented by MOLM-16, HL-60 and MV-4-11 and related diseases of the myeloid cells. The compound shown in the formula I or the salt thereof or the related pharmaceutical composition provided by the invention has excellent in-vivo and in-vitro inhibitory activity, good druggability and high bioavailability, and does not have obvious injury to visceral organs. Therefore, the compound shown in the formula I or the salt thereof and the related pharmaceutical composition have huge clinical application prospects.

INDOLE AHR INHIBITORS AND USES THEREOF

The present invention provides compounds useful as inhibitors of AHR, compositions thereof, and methods of using the same.

HISTONE METHYLTRANSFERASE EZH2 INHIBITOR, PREPARATION METHOD AND PHARMACEUTICAL USE THEREOF

The invention relates to a histone methyltransferase EZH2 inhibitor, a preparation method and pharmaceutical use thereof. In particular, the invention relates to a compound represented by the general formula (I), a preparation method thereof, a pharmaceut